Results 161 to 170 of about 97,918 (260)

Morphotype Bias, Morph Specific Recruitment and No Elevation‐Life History Relation in High Altitude Mesquite Lizard Populations

Integrative Zoology, EarlyView.
Site‐level differences in population growth (λ) and phenotype frequencies. Mountain silhouettes represent the three study sites. Morph relative abundances are shown in the colored vertical bar. Point estimates and confidence intervals of λ for each site are displayed below, with the dashed line marking the threshold for demographic stability (λ = 1 ...
Brasil Canales‐Gordillo, Wendy L. Cuandón‐Hernández, José L. Jaramillo‐Alba, Jorge I. Chiu‐Valderrama, Hibraim A. Pérez‐Mendoza   +4 more
wiley   +1 more source

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers

Journal of the American Heart Association, EarlyView., 2021
Background Impaired myocardial blood flow (MBF) in the absence of epicardial coronary disease is a feature of hypertrophic cardiomyopathy (HCM). Although most evident in hypertrophied or scarred segments, reduced MBF can occur in apparently normal segments.
Rebecca K. Hughes, Claudia Camaioni, João B. Augusto, Kristopher Knott, Ellie Quinn, Gabriella Captur, Andreas Seraphim, George Joy, Petros Syrris, Perry M. Elliott, Saidi Mohiddin, Peter Kellman, Hui Xue, Luis R. Lopes, James C. Moon   +14 more
wiley   +1 more source

Trends and disparities in infant mortality from intrauterine hypoxia and birth asphyxia in the United States, 1999-2023. [PDF]

Front Pediatr
Horio N, Kennedy K, Haase K, Foley O, Tauseef A.   +4 more
europepmc   +1 more source

Evolving Trends in Laryngeal Cancer Mortality in the United States, 1999–2024: A Population‐Based Analysis With Subgroup Stratified Trends through 2020

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Laryngeal cancer mortality in the United States declined from 1999 to 2016, followed by a plateau through 2024. Disparities persist, with males and NH‐Black populations experiencing disproportionately higher mortality. Continued regional and demographic differences highlight the need to strengthen prevention, early detection, and targeted public health
Aryan Tareen, Anoud Khan, Saqib Raza Khan, Muhammad Faez Tahir, Fatima Ibrahim Ahmed, Imaan Shoaib Mufti, Maryam Karam, Rija Tahir, Rinad Akhtar, Muntaha Irfan, Riham Zubair   +10 more
wiley   +1 more source

FDG-PET/CT-based treatment response predicts recurrence and overall survival in locally advanced cervical cancer. [PDF]

BMC Med Imaging
Markus M, Sartor H, Bjurberg M, Minarik D, Trägårdh E.   +4 more
europepmc   +1 more source

Nasal Epithelial Immune Signatures Are Associated With Age‐Dependent Asthma Trajectories in Early Life

Allergy, EarlyView.
Nasal epithelial transcriptomics identified three cytokine‐associated epithelial immune programs linked to childhood asthma phenotypes. Age‐associated epithelial polarization shifted from IFN/type‐17‐associated toward type‐2‐associated programs after 3 years of age.
Constanze A. Jakwerth, Sabina Illi, Helen Charles, Madlen Oelsner, Amr A. Gabr, Ulrich M. Zissler, Anna Erb, Martin Feuerherd, Felix Drost, Maren Büttner, Benjamin Schubert, Nicole Maison, Jimmy Omony, Markus Weckmann, Ruth Grychtol, Anna‐Maria Dittrich, Svenja Foth, Chrysanthi Skevaki, Tobias Trojan, Silke van Koningsbruggen‐Rietschel, Gesine Hansen, Thomas Bahmer, Klaus F. Rabe, Folke Brinkmann, Matthias Volkmar Kopp, Ulrike Protzer, Adam M. Chaker, Bianca Schaub, Erika von Mutius, Carsten B. Schmidt‐Weber, the ALLIANCE Study Group as part of the German Center for Lung Research (DZL), Mira Bürk, Sybille Contento, Markus Ege, Kristina Gottschau, Silvia Gschwendtner, Alexander Hose, Lena Lagally, Michael Schloter, Lena Ullemeyer, Esther Zeitlmann, Mustafa Abdo, Heike Biller, Karoline I. Gaede, Clara Haug, Nikolas Jacobs, Anne‐Marie Kirsten, Inke R. König, Lea Kronziel, Gyde Nissen, Frauke Pedersen, Loana Pennerd, Isabell Ricklefs, Vera Veith, Henrik Watz, Marie Bickes, Mifflin‐Rae Calvero, David S. DeLuca, Svenja Gaedcke, Anika Habener, Christine Happle, Adan Chari Jirmo, Bin Liu, Lennart Riemann, Nicolaus Schwerk, Inga Jerrentrup, Harald Renz, Stefanie Weber, Miguel A. Alejandre Alcazar, Samira Blau, Ernst Rietschel, Jan‐Christoph Thomassen   +71 more
wiley   +1 more source

Correlation of Echocardiographic Right Ventricular Functional Parameters with CMR-Derived Right Ventricular Ejection Fraction in Pulmonary Hypertension: A Systematic Review and Meta-Analysis. [PDF]

Diagnostics (Basel)
Ahmed F, Zulfiqar A, Ali R, Shah SS, Aliha S, Khan MS, Qasim S, Campwala M, Khalid M, Sood A, Iqbal U, Tahir HB, Dalir N, Alam T, Khaleel AA, Maligireddy AR, Yadav R, Taha A, Ghani A, Alenezi F.   +19 more
europepmc   +1 more source

Avatrombopag for persistent and chronic immune thrombocytopenia in children: A post hoc analysis of clinical characteristics of response from a phase 3b clinical trial

British Journal of Haematology, EarlyView.
Summary Avatrombopag treatment resulted in significantly higher platelet response rates in patients when compared with placebo in a phase 3b study of patients with paediatric immune thrombocytopenia (ITP) (NCT04516967). These post hoc analyses of the 12‐week core phase further assessed the efficacy of avatrombopag, considering the influence of baseline
Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Sule Unal, John Grainger, Amanda B. Grimes, Michele P. Lambert, Jessica Zhang, Brian D. Jamieson, Faizan Sattar, Scott Kolodny, Michael Vredenburg, on behalf of the AVA‐PED‐301 Study Group   +12 more
wiley   +1 more source

Early quantitative stress-perfusion cardiac magnetic resonance reveals perfusion abnormalities consistent with coronary microvascular dysfunction in MINOCA patients with otherwise normal cardiac magnetic resonance findings. [PDF]

Sci Rep
Sahar R, Lenell J, Lindahl B, Montelius AM, Berglund J, Grinnemo KH, Malinovschi A, Baron T.   +7 more
europepmc   +1 more source

Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma: Phase 1b dose‐escalation study

British Journal of Haematology, EarlyView.
Summary Glofitamab was investigated with obinutuzumab/rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (G/R‐CHOP) in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma (B‐NHL) who had ≥1 prior obinutuzumab/rituximab‐containing therapy (NCT03467373). The primary end‐point was to determine the optimal biological dose of
William Townsend, Nilanjan Ghosh, Martin Hutchings, Michael Dickinson, Monica Tani, Armando Santoro, Michael Crump, Amitkumar Mehta, Reinhard Marks, Martin Weisser, Martin Barrett, Chun Wu, Derrick Kaufman, Katharina Lechner, Pauline Baumlin, Pontus Lundberg, Max S. Topp   +16 more
wiley   +1 more source